Samrat Pharmachem (BOM:530125) Cyclically Adjusted Book per Share: ₹153.54 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530125 Samrat Pharmachem Ltd BOM:530125
63 GF Score
Price ₹247.85
GF Value ₹362.79
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Samrat Pharmachem Cyclically Adjusted Book per Share?

Samrat Pharmachem BOM:530125 -0.04% 63 Cyclically Adjusted Book per Share is ₹153.54 as of Mar. 2026. GuruFocus rates BOM:530125 with a GF Score™ of 63/100 and a GF Value™ of ₹362.79 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Samrat Pharmachem's adjusted book value per share for the three months ended in Mar. 2026 was ₹220.645. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹153.54 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Samrat Pharmachem's average Cyclically Adjusted Book Growth Rate was 16.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 17.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Samrat Pharmachem was 19.30% per year. The lowest was 17.20% per year. And the median was 18.25% per year.

As of today (2026-07-30), Samrat Pharmachem's current stock price is ₹247.85. Samrat Pharmachem's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ₹153.54. Samrat Pharmachem's Cyclically Adjusted PB Ratio of today is 1.61.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Samrat Pharmachem was 12.12. The lowest was 1.29. And the median was 3.37.


Samrat Pharmachem  (BOM:530125) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Samrat Pharmachem's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=247.85/153.54
=1.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Samrat Pharmachem was 12.12. The lowest was 1.29. And the median was 3.37.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Samrat Pharmachem Cyclically Adjusted Book per Share Related Terms


Samrat Pharmachem Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Samrat Pharmachem's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Samrat Pharmachem Cyclically Adjusted Book per Share Chart

Samrat Pharmachem Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.90 95.40 113.27 132.35 153.54

Samrat Pharmachem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.35 0.00 144.26 0.00 153.54

BOM:530125 vs DOW: Cyclically Adjusted Book per Share Comparison

For the Chemicals subindustry, Samrat Pharmachem's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samrat Pharmachem Cyclically Adjusted PB Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Samrat Pharmachem's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Samrat Pharmachem's Cyclically Adjusted PB Ratio falls into.


BOM:530125
63GF Score
Samrat Pharmachem Ltd BOM:530125
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Samrat Pharmachem Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Samrat Pharmachem's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=220.645/164.2724*164.2724
=220.645

Current CPI (Mar. 2026) = 164.2724.

Samrat Pharmachem Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.000 105.961 0.000
201609 46.674 105.961 72.359
201612 0.000 105.196 0.000
201703 49.561 105.196 77.394
201706 0.000 107.109 0.000
201709 53.304 109.021 80.318
201712 0.000 109.404 0.000
201803 59.972 109.786 89.736
201806 0.000 111.317 0.000
201809 59.815 115.142 85.338
201812 0.000 115.142 0.000
201903 64.941 118.202 90.252
201906 0.000 120.880 0.000
201909 75.857 123.175 101.167
201912 0.000 126.235 0.000
202003 78.653 124.705 103.609
202006 0.000 127.000 0.000
202009 85.895 130.118 108.441
202012 0.000 130.889 0.000
202103 95.912 131.771 119.569
202106 0.000 134.084 0.000
202109 108.026 135.847 130.630
202112 0.000 138.161 0.000
202203 151.527 138.822 179.307
202206 0.000 142.347 0.000
202209 200.974 144.661 228.219
202212 0.000 145.763 0.000
202303 204.348 146.865 228.569
202306 0.000 150.280 0.000
202309 204.716 151.492 221.987
202312 0.000 152.924 0.000
202403 210.346 153.035 225.792
202406 0.000 155.789 0.000
202409 224.643 157.882 233.735
202412 0.000 158.323 0.000
202503 232.363 157.552 242.275
202506 0.000 159.755 0.000
202509 228.722 162.289 231.517
202512 0.000 163.281 0.000
202603 220.645 164.272 220.645

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₹153.54 mean?
Samrat Pharmachem (BOM:530125) has a Cyclically Adjusted Book per Share of ₹153.54 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Samrat Pharmachem and its competitors.
Is Samrat Pharmachem's Cyclically Adjusted Book per Share too high?
Samrat Pharmachem's current Cyclically Adjusted Book per Share is ₹153.54. Overall, Samrat Pharmachem has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Samrat Pharmachem's Cyclically Adjusted Book per Share compare to DOW?
Samrat Pharmachem's Cyclically Adjusted Book per Share of ₹153.54 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Chemicals company?
A good Cyclically Adjusted Book per Share depends on the Chemicals industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Samrat Pharmachem and its competitors. Samrat Pharmachem's current Cyclically Adjusted Book per Share is ₹153.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Samrat Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Samrat Pharmachem (BOM:530125) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹362.79, compared to a current price of ₹247.85 — trading 31.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is ₹153.54. Samrat Pharmachem's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Samrat Pharmachem (BOM:530125), the current Cyclically Adjusted Book per Share is ₹153.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Samrat Pharmachem (BOM:530125) Overvalued in 2026?

Based on GuruFocus' analysis, Samrat Pharmachem stock appears to be undervalued. The current stock price of ₹247.85 is trading 31.7% below its estimated GF Value™ of ₹362.79. GuruFocus considers Samrat Pharmachem to be Significantly Undervalued.

Key valuation signals for BOM:530125:

  • Cyclically Adjusted Book per Share: ₹153.54
  • GF Value™: ₹362.79 vs. price of ₹247.85 (31.7% below fair value)
  • GF Score™: 63/100 with 3 warning signs

No single metric tells the full story. See the BOM:530125 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Samrat Pharmachem Business Description

Address M. A. Road, 701/702, Business Square, Andheri (West), Mumbai, MH, IND, 400 058
Samrat Pharmachem Ltd is a producer of pharmaceutical chemicals. The principal activity of the company is to manufacture Iodine salts and bromine salts. Its product portfolio consists of potassium iodate, potassium iodide, methyl iodide, and copper iodide. Its products are used in various industries like pharmaceuticals and chemicals.
63GF Score

Get the complete analysis for BOM:530125

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹247.85
Price
₹362.79
GF Value